2 ms·
The US spent quite a lot, but still came in very conservative. The initial orders (combined) of Pfizer/Moderna were enough for 75 million people. Vs likely dema
by maxerickson 6y ago
The US spent quite a lot, but still came in very conservative. The initial orders (combined) of Pfizer/Moderna were enough for 75 million people. Vs likely demand of at least 200 million.
For $40 billion (which we are estimated to lose every 4 or 5 days), we could have ordered 300 million of each of them.
There's likely some materials that are scarce enough not to waste (we need billions of vaccines globally), but production also seems to have started very late in the trial/approval process.
- Throwawayaerlei 6y agoSources? Because everything I've read is that each got a 100 million dose initial order, so that's 100 million people total to begin with. Moderna was already part of Operation Warp Speed, the contract signed 11 August 2020 according to Wikipedia. Pfizer refused to be a part of it, but in July 2020 signed a 100 million dose order contingent on getting regulatory approval. Both have since signed additional 100 million dose contracts, and Moderna an option for an additional 150 million. Operation Warp Speed worked with Moderna, spent a lot of money on both them and various parts of the supply chain to do the best to manufacture this new type vaccine as fast as possible, and I've not heard anything about their failing in their promises. Whereas Pfizer initially went it alone, and starting in December has been failing to keep their promises everywhere, now even shutting down their plant in Belgium to increase capacity.
- maxerickson 6y agoYeah, I appear to have misunderstood or misremembered something, the Moderna order was 100 million doses. It's very hard to evaluate whether they have proceeded on the fastest possible timeline scaling up the production. Which whether their goals were ambitious enough is just as important as whether they are hitting them.
- bluGill 6y agoThe US bet on many different vaccines, most of which haven't arrived yet, but are still on track. On hindsight we can say we should have bet on Pfizer and Moderna, and screwed the rest - such a bet would have allowed them to increase their supply even faster. However that is hindsight, at the time we didn't have any reason to believe their vaccine would even work at all - while the ones we are waiting on we had good reason to believe would work. That some of the ones we are waiting on seem to be much worse is a shock to everyone. Even this much worse is a qualified - they are doing within the expected range, it is just that mRNA is doing so well that makes them bad.
- maxerickson 6y agoWe could have bet 10 times the resources. Cheap compared to the pandemic!
- Throwawayaerlei 6y agoYou keep saying this, but you haven't demonstrated any way in which pouring more money into the process would have significantly speeded up production. Do Intel's massive financial resources allow them to profitably manufacture chips on their 10 nm and 7 nm nodes?
- maxerickson 6y agoI mean, no one has demonstrated that it would not have either, and if you look at my comments, I've acknowledged that we don't have the information to evaluate it. And who cares if we just pissed away $40 billion dollars failing to speed things up. But look at the distribution. Pfizer submitted their results around Thanksgiving. The FDA decided they'd look at them in a couple weeks. The Federal answer to states complaining that they didn't have funds to get programs running was "figure it out". Stupid, even if you ardently think that states should be the primary vehicle of government.
- Throwawayaerlei 6y agoThe Federal answer to states complaining that they didn't have funds to get programs running was "figure it out". Maybe you shouldn't live in a notoriously failed state when it comes to COVID-19 management (Michigan, which outlawed the sale of garden seeds!, Vermont is the only other state to go that far), we seem to have arrived at the gravamen of your issue with not enough money being spent. My home state is doing just fine in distributing it, spent months planning and is not making excuses about not having enough money. It is calling up the National Guard now that targets of the vaccine are changing, but that was part of the plan all along. And as I previously noted, Pfizer/BioNTech approved Friday, vaccine in hand in my small city Monday morning, first front line healthcare workers vaccinated that day using one vial. Then things really got into gear.